Staphylococcus aureus bacteremia: Using echocardiography to guide length of therapy

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 6, 2003, Pages 517-533

  Kim, Alice I ^a   Adal, Karim A ^a   Schmitt, Steven K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; NAFCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL ENDOCARDITIS; COST EFFECTIVENESS ANALYSIS; DEVICE REMOVAL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG POTENTIATION; ECHOCARDIOGRAPHY; EMPIRICISM; HEART VALVE PROSTHESIS; HUMAN; MEDICAL EXPERT; PROSTHESIS INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 0038209290     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.6.517     Document Type: Review

References (73)

1. Nolan C, Beaty H. Staphylococcus aureus bacteremia: Current clinical patterns. Am J Med 1976; 60:495-500.
2. Mylotte J, McDermott C, Spooner J. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9:891-907.
3. Mortara L, Bayer A. Staphylococcus aureus bacteremia and endocarditis: New diagnostic and therapeutic concepts. Infect Dis Clin North Am 1993; 7:53-68.
4. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from October 1986-April 1998, Issued June 1998.
5. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91:86S-89S.
6. Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol 1992; 13:725-737.
7. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40:135-136.
8. Lowy F. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-532.
9. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Micro Rev 1997; 10:505-520.
10. Tuazon CU, Perez A, Kishaba T et al. Staphylococcus aureus among insulin-injecting diabetic patients. An increased carriage rate. JAMA 1975; 231:1272.
11. Kirmani N, Tuazon CU, Muray HW, et al. Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978; 138:1657-1659.
12. Tuazon CU, Sheagren JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974; 129:725-727.
13. Von Eiff C, Becker K, Machka M, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344:11-16.
14. Tuazon CU, Sheagren JN. Staphylococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med 1975; 82:788-790.
15. Jensen A, Wachmann C, Poulsen K, et al. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999; 159:1437-1444.
16. Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100:509-516.
17. Romero-Vivas J, Margarita R, Fernandez C, Picazo J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21:1417-1423.
18. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001; 32:108-115.
19. Maki DG. Infections due to infusion therapy. In: Bennet JV, Brachman PS, editors. Hospital Infections, 3rd ed. Boston: Little, Brown, 1992.
20. Weinstein MP, Towns ML, Quartney SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24:584-602.
21. Fowler V, Sanders L, Kong L, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999; 28:106-114.
22. Mylotte JM, Beam TR, Allen JC. Staphylococcus aureus bacteremia: a prospective study. South Med J 1983; 76:1131-1135.
23. Libman H, Arbeti RD. Complication associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984; 144:541-545.
24. Eng RH, Bishburg E, Smith SM, et al. Staphylococcus aureus bacteremia during therapy. J Infect Dis 1987; 155:1331-1335.
25. Fowler VG, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30:1072-1078.
26. Ringberg H, Thoren A, Lilja B. Metastatic complications of Staphylococcus aureus septicemia: to seek is to find. Infection 2000; 28(3):132-136.
27. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104:1029-1033.
28. Sanabria TJ, Alpert JS, Goldberg R, Pape LA., Cheeseman SH. Increasing frequency of staphylococcal infective endocarditis: experience at a university hospital, 1981 through 1988. Arch Intern Med 1990; 150:1305-1309.
29. Bouza E, Menasalvas A, Munoz P, et al. Infective endocarditis - A prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine 2001; 80:298-307.
30. Mirimanoff RO, Glauser MP. Endocarditis during Staphylococcus aureus septicemia in a population of non-drug addicts. Arch Intern Med 1982; 142:1311-1313.
31. Fowler VG, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30:1072-1078.
32. Fang G, Keys TF, Gentry LO, et al. Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med 1993; 119:560-567.
33. Demuth P, Gerding D, Crossley K. Staphylococcus aureus bacteriuria. Arch Intern Med 1979; 139:78-80.
34. Lee B, Crossley K. The association between Staphylococcus aureus bacteremia and bacteriuria. Am J Med 1978; 65:303-306.
35. Bayer A. Staphylococcal bacteremia and endocarditis. Arch Intern Med 1982; 142:1169-1177.
36. Musher DM, McKenzie SO. Infections due to Staphylococcus aureus. Medicine 1977; 56:383-409.
37. Mugge A. Echocardiographic detection of cardiac valve vegetations and prognostic implications. Infect Dis Clin North Am 1993; 7(4):877-898.
38. Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991; 18:391-397.
39. Vered Z, Mossinson D, Peleg E, Kaplinksy E, Motro M, Beker B. Echocardiographic assessment of prosthetic valve endocarditis. Eur Heart J 1995; 16(suppl B):63-67.
40. Morguet AJ, Werner GS, Andreas S, Kreuzer H. Diagnostic value of transesophageal compared with transthoracic echocardiography in suspected prosthetic valve endocarditis. Herz 1995; 20:390-398.
41. Daniel WG, Mugge A, Grote J, et al. Comparison of transthoracic and transesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol 1993; 71:210-215.
42. Herrera CJ, Chaudry FA, DeFrino PF, et al. Value and limitations of transesophageal echocardiography in evaluation prosthetic and bioprosthetic valve dysfunction. Am J Cardiol 1992; 69:697-699.
43. Daniel WG, Mugge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324: 795-800.
44. Mugge A, Daniel WG, Frank G, et al. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989; 14:631-638.
45. Sabath LD, Postic B, Finland M. Methicillin treatment of severe staphylococcal disease: observations in 146 cases. N Engl J Med 1962; 267:1049-1057.
46. Small P, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug abusers. Antimicrob Agents Chemother 1990; 34:1227-1231.
47. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991; 115:674-680.
48. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR 2002; 51:565-566.
49. Fridkin SK, McDougal LK, Mohammed J, et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003; 36:429-439.
50. Public health dispatch: vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR 2002; 288:2116-2117.
51. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and nonaddicts: a prospective study. Ann Intern Med 1982; 97:496-503.
52. Iannini P, Crossley K. Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann Intern Med 1976; 84:558-560.
53. Fowler V, Sanders L, Sexton D, et al. Outcome of Staphylococcus aureus bacteremia according to compliance recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27:478-486.
54. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990; 89:137-141.
55. Gransden WR, Eykyn SJ, Phillips I. Staphylococcus aureus bacteremia: 400 episodes in St. Thomas Hospital. Br Med J 1984; 288:300-303.
56. Lautenschlager S, Herzog C, Zimmerli W. Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical definitions. Clin Infect Dis 1993; 16:567-573.
57. Kuikka A, Valtonen V. Improved outcome of Staphylococcus aureus bacteremia. Infect Dis Clinic Pract 1994; 3:282-287.
58. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-37.
59. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Intern Med 1997; 242:15-22.
60. Feranandez-Guerrero ML, Verdejo C, Azofra J, de Gorgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995; 20:16-23.
61. Jaffe WM, Morgan DE, Pearlman AS, Otto CM. Infective endocarditis, 1983-1988: echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol 1990; 15:1227-1233.
62. Lancellotti P, Galiuto L, Albert A, et al. Relative value of clinical and transesophageal echocardiographic variables for risk stratification in patients with infective endocarditis. Clin Cardiol 1998; 21:572-578.
63. Harris LF. Staphylococcus aureus endocarditis in community hospitals. Alabama Med 1991; 60(11):9-10.
64. Watanakunakorn C. Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. Arch Intern Med 1994; 154:2330-2335.
65. Roder BL, Wandall DA, Frimodt-Moller N, et al. Clinical features of Staphylococcus aureus endocarditis: A 10-year experience in Denmark. Arch Intern Med 1999; 159:462-469.
66. Espersen F, Frimodt-Moller N. Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med 1986; 146:118-121.
67. Frimodt-Moller N, Espersen E, Rosdahl VT. Antibiotic treatment of Staphylococcus aureus endocarditis. A review of 119 cases. Acta Med Scand 1987; 222:175-182.
68. Tornos P, Sanz E, Permanyer-Miralda G, Almirante B, Planes AM, Soler-Soler J. Late prosthetic valve endocarditis: Immediate and long term prognosis. Chest 1992; 101:37-41.
69. Yu VL, Fang GD, Keys TF, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medically therapy only. Ann Thorac Surg 1994; 58:1073-1077.
70. Roder BL, Wandall DA, Espersen F, et al. A study of 47 bacteremic Staphylococcus aureus endocarditis cases: 23 with native valves treated surgically and 24 with prosthetic valves. Scand Cardiovasc J 1997; 31:305-309.
71. Kuyvenhoven JP, van Rijk-Zwikker GL, Hermans J, Thompson J, Huysmans HA. Prosthetic valve endocarditis: Analysis of risk factors for mortality. Eur J Cardiothorac Surg 1994; 8:420-424.
72. Harbath S, Rutschmann O, Sudre P et al. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158:182-189.
73. Lundbery J, Nettleman M, Costigan M, Bentler S, Dawson J, Wenzel RP. Staphylococcus aureus bacteremia: The cost-effectiveness of long term therapy associated with infectious diseases consultation. Clin Perform Qual Health Care 1988; 6(Jan/Feb/Mar):9-11.